Background: Complete blood count parameters have been introduced to be diagnostic biomarkers for many cancer-related diseases associated with inflammatory process. The aim of our study was to detect whether there is any relationship between benign or malignant endometrial pathologies and complete blood count parameters.
Methods: Four hundred and sixteen patients with a complaint of abnormal uterine bleeding who admitted to Zeynep Kamil Women and Children's Health Training and
Research hospital between 2013 and 2016 and undergoing endometrial biopsy were included in the study. The patients were evaluated in three groups as follows: endometrial carcinoma (n: 97), endometrial hyperplasia (n: 135), and healthy control (n: 184) groups. All patients had a complete blood count on the day of biopsy or within the week of the biopsy, and the presence of a relationship between complete blood count parameters and benign or malignant endometrial disease was investigated.
Results: Mean corpuscular volume measurements were found to be significantly higher in endometrial carcinoma (P = .018) and endometrial hyperplasia (P = .001) groups compared to the control group. While red cell distribution width measurements were found to be significantly lower in patients with endometrial carcinoma group compared to other groups (P < .01); the area under curve obtained for MPV is 58.7% to determine endometrial carcinoma.
Conclusion:
Mean corpuscular volume and red cell distribution width are bio-markers that we can use as the predictive marker in patients with endometrial carcinoma and which are cheap, repeatable, and readily obtainable from complete blood count panels and promising.
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2 Currently, there is no place for routine screening in women at high risk for endometrial carcinoma. However, annual endometrial sampling is recommended in women at very high risk for endometrial carcinoma due to HNPCC starting with 30-35 years old. Due to their angiogenic, metastatic, and proteolytic activities, platelets have a major role in the background of inflammation. 4 Mean platelet volume (MPV) is an important inflammatory marker indicating platelet activation. 5 Until today, the relationship between hematological parameters such as MPV, RDW, NLR, PLR, PDW were investigated, diagnostic, and prognostic features of these parameters with their role in metastatic activities of cancer were evaluated.
6-8
Today, we can evaluate the systemic inflammation or systemic inflammatory response developing against tumor cell in the body rapidly and practically with hematological parameters. In this study, we aimed to assess the relationship between hematological parameters and endometrial carcinoma, which was a solid gynecological tumor, and additionally endometrial hyperplasia, which was a preliminary pathological finding of this carcinoma. The patients were assessed in three groups. Group 1 (n: 97): endometrial carcinoma group, Group 2 (n: 135): endometrial hyperplasia group, and Group 3 (n: 184): control group.
| MATERIAL S AND ME THODS

Inclusion criteria were as follows:
Patients who admitted to our hospital with a diagnosis of abnormal uterine bleeding (AUB) and who had complete blood count parameters at the biopsy day or within the previous week before biopsy day and who had no marked pathology in the gynecological examination and laboratory tests which would explain AUB.
Exclusion criteria were as follows:
The patients with hyperprolactinemia, abnormal thyroid function test results, chronic inflammatory disease, malignancies, hematological disorders, patients receiving anticoagulant therapy, and the individuals receiving hormone therapy within last 12 months.
Blood samples were taken in laboratory tubes with EDTA at the biopsy day or in the previous week before the procedure and analyzed by automated hematology analyzer (CELL-DYN 3700, Abbott Diagnostics, Abbott Park, IL) within 60 minutes following venipuncture.
| Pathological examination
Histopathological pre-diagnosis was made in all patients with endometrial sampling performed under general or local anesthesia. All endometrial surfaces were sampled by entering the uterine cavity with sharp curette following cervical dilation.
The histological samples were assessed by the pathologists.
The results of EH (endometrial hyperplasia) were classified into four categories: (i) simple EH without atypia, (ii) simple atypical EH, (iii) complex atypical EH, and (iv) complex EH without atypia.
The other pathology results not reported as endometrial hyperplasia and cancer such as proliferative endometrium, secretory endometrium, endometrial polyp, atrophic endometrium, and endometrial cell fragments were included under the topic of the healthy control group. 
| Statistical analysis
NCSS
| RE SULTS
Comparisons of demographic parameters between three groups are shown in Table 1 . The mean age of group 1 was significantly higher than group 2 and control group (P < .01). The parity of group 1 was significantly higher than group 2 and control group (P < .01). The parity was similar between group 2 and control group. The rates of systemic diseases including diabetes mellitus and hypertension in group 1 were higher than group 2 and control group (P < .01). The rate of Diabetes mellitus was similar among group 2 and control group, but the rate of hypertension was significantly higher in the control group than group 2 (P < .05).
Comparisons of hematological parameters according to groups are shown in Table 2 . While hemoglobin and hematocrit levels were found to be significantly lower in endometrial carcinoma group (group 1) compared to endometrial hyperplasia group (P < .01) and control group (P < .01); hemoglobin and hematocrit levels were found to be significantly lower in endometrial hyperplasia group compared to the control group (P < .01).
There were no significant differences between groups with respect to leukocyte counts, neutrophil counts, lymphocyte counts, and platelet counts (P > .05).
While MPV measurements were significantly higher in endometrial carcinoma group (P = .018) and endometrial hyperplasia group (P = .001) compared to the control group; it was determined that there was no significant difference between endometrial carcinoma group and endometrial hyperplasia group with respect to MPV measurements (P > .05).
While RDW measurements were significantly lower in endometrial carcinoma patients compared to endometrial hyperplasia group (P = .004) and control group (P = .007) (P < .01); no significant difference was observed between endometrial hyperplasia group and control group with respect to RDW measurements (P > .05).
It was observed that there were no statistically significant differences between groups with respect to neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) (P > .05).
ROC curve analysis was performed for neutrophil, lymphocyte, platelet counts, MPV, RDW, NLR, PLR measurements to determine endometrial carcinoma in the groups including endometrial carcinoma patients and healthy controls (Figure 1 ). Analysis revealed that, while a significant difference was determined in MPV (P = .018) and RDW (P = .003) measurements (P < .05); no significant difference was determined in other measurements (P > .05). The area under the ROC curve obtained for MPV is 58.7% with a standard error of 3.6%, and the rate obtained for RDW is 39.3% with a standard error of 3.6%.
| D ISCUSS I ON
Endometrial carcinoma is the most commonly observed malignancy among gynecological neoplasms. 9 Since the demonstration of the relationship between cancer and inflammation for the first time, many studies were performed on this topic. While the mechanism remains uncertain, neutrophils, lymphocytes, and platelets with various cytokines, growth factors, and local mediators have been shown to have a contribution to tumor development and metastatic potential of the tumor. 10 Endometrial carcinoma is the tumor group, which has lower number of investigations among other solid gynecological tumors. It is well-known that, patients with endometrial carcinoma are older adults. Also, we observed that patients with endometrial carcinoma constituted the oldest age group in our study. Estrogen production ceases after menopause and most of the estrogens in the circulation are produced as a result of peripheral aromatization of androgens to estrogens in the adipose tissue. It was shown that proinflammatory cytokines could stimulate aromatase activity in the adipose tissue and therefore increased estrogen production and bioavailability.
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This condition explains why endometrial carcinoma is seen in elderly women and especially obese individuals.
Diabetes mellitus and hypertension are the conditions increasing the risk for endometrial carcinoma. Here, a metabolic syndrome associated with obesity with insulin resistance, restricted physical activity, low levels of HDL, high levels of triglyceride, diabetes mellitus, and hypertension have been considered to be responsible for increased risk of endometrial carcinoma. 12 In our study, we also found that the rates of diabetes mellitus and hypertension were significantly higher in endometrial carcinoma group compared to endometrial hyperplasia group and control group. Platelet number and MPV were shown to be the most important two parameters indicating platelet activity. Increased levels of MPV are considered an indicator of the large and active platelets in peripheral circulation. Elevated MPV levels are considered to be a consequence of systemic inflammatory response which plays a critical role in the development and progression of cancer. 5 Increased lev-
TA B L E 1 Evaluation of descriptive characteristics according to the groups
els of MPV of peripheral blood have been demonstrated in various
types of cancer such as hepatocellular carcinoma, ovarian cancer, and breast cancer.
13-15
We determined no significant difference between groups with respect to the platelet counts. In the study performed by Gorelick et al in patients with endometrial carcinoma, the authors reported that preoperative thrombocytosis was a poor prognostic factor. 16 In our study, we found that preoperative MPV measurements were significantly higher in endometrial carcinoma group and endometrial hyperplasia group compared to the control group. In the study performed by Karateke et al in patients with endometrial carcinoma and endometrial hyperplasia, the highest MPV values were determined in the endometrial carcinoma group and the lowest MPV values were determined in the control group. Karateke et al compared the groups with respect to white blood cell counts, platelet counts, and hemoglobin levels and they reported that there was no significant difference between groups. 17 In our study, we found the lowest hemoglobin and hematocrit levels in endometrial carcinoma group.
In the study performed by Oge et al in 310 patients with endometrial adenocarcinoma and 250 healthy controls, the lowest hemoglobin levels and the highest MPV levels were reported in patients with advanced-stage endometrial cancer compared to patients with early-stage endometrial cancer and the control group. In the same study, no significant difference was reported between all patients with endometrial adenocarcinoma and healthy controls with respect to hemoglobin levels and platelet counts. In another study performed by Ural et al patients with endometrial hyperplasia and endometrial carcinoma diagnosed with an endometrial biopsy and healthy controls were compared and the relationship between NLR, PLR, PDW, and endometrial disease was investigated. 20 The authors reported that NLR and PDW were significantly higher in patients with endometrial carcinoma compared to endometrial hyperplasia group and control group, but PLR was similar in the groups.
In a study performed by Abide et al the relationship between mole pregnancies and hematological parameters was compared and the authors reported that MPV was significantly higher in cases with molar pregnancy compared to healthy pregnant, but PLR was significantly lower in cases with molar pregnancy compared to healthy controls. NLR was found to be similar in both groups. 21 Another inflammatory marker RDW is an indicator of heterogeneity in the size of circulating erythrocytes and used to determine the amount of anisocytosis in the peripheral blood. RDW is an indicator of impaired erythropoiesis and abnormal red blood cell survival. 22 In recent years, many studies investigating the relationship between RDW and cardiovascular disease and cancer were performed. RDW was proved to be an independent prognostic factor for many cancers such as lung cancer, prostate cancer, and chronic lymphocytic leukemia. [6] [7] [8] In our study, we found that RDW measurements were significantly lower in patients with endometrial carcinoma compared to patients with endometrial hyperplasia and healthy controls. In a study performed by Kemal et al the patients with endometrial carcinoma and cases with the benign endometrial disease were compared and the authors determined that RDW levels were significantly higher in endometrial carcinoma group. 23 In another study performed by Abide et al the relationship between blood count parameters and diagnosis of placental invasion anomalies was assessed. We know that cancer cell invasion has many common features with trophoblastic invasion. 24 Abide et al determined that RDW levels were significantly less in cases with placental invasion anomalies compared to the cases without placental invasion anomalies and MPV levels were significantly higher in cases with placental invasion anomalies compared to the cases without placental invasion.
However, as the number of study about RDW and cancer was increased different interpretations emerged. Until now, only one metaanalysis was performed to determine the prognostic value of RDW in cancer patients. 25 In consequence of this meta-analysis, Hu et al decided that elevated RDW was an unfavorable predictor of prognosis in patients with cancers. The inclusion of a limited number of tumor types in this study and the number of studies related to each type of cancers (less than 5) were the major limitation of this meta-analysis.
Additionally, different cutoff values of RDW and retrospective studies were among reasons of limitation of this meta-analysis. Some other inflammatory markers have been investigated to detect cases with endometrial cancer such as CRP, IL6, and IL1Ra, authors found significant associations between these markers and endometrial cancer, and authors concluded that chronic inflammation which was thought to be secondary to insulin resistance and estrogen production might be a mediator for the obesity-related increase in risk of endometrial cancer independently from these two pathways 26 ; however, these markers are not widely available to be used so we do not have the data regarding other possible inflammatory markers for the endometrial cancer prediction.
In conclusion, we think that MPV and RDW which are cheap, repeatable, and readily obtainable from complete blood count panels can be used as diagnostic biomarkers for endometrial carcinoma. F I G U R E 1 ROC curve plot for endometrial Ca
